Medical Economics November 17, 2021

The “Cures 2.0” bill, if signed into law, would expand medical research, aid development of new therapies and expand telehealth.

Editor’s note: This article was first published on Chief Healthcare Executive.

Healthcare and research advocates are cheering the introduction of a new bill that supporters say will spur new cures and therapies and expand telehealth access.

U.S. Reps. Diana DeGette, D-Colo., and Fred Upton, R-Mich., introduced the “Cures 2.0” bill Tuesday. The measure would create the new federal research agency proposed by President Joe Biden: the Advanced Research Projects Agency for Health, or ARPA-H.

The bill would offer $6.5 billion to finance the agency for three years, the amount the White House requested.

The agency is designed to undertake novel,...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Congress / White House, Cures Act, Digital Health, Govt Agencies, Health IT, Provider, Technology, Telehealth
What Washington wants in Cures 2.0
How ONC Can Strengthen Its HTI-1 Rule To Ensure Transparency, Fairness, And Equity In AI
Providers Take Note: The Common Agreement Version 2.0 Released
Advancing Nationwide, Trusted Health Information Networks
Cures Act tied to quicker release, access of imaging reports

Share This Article